Active — Not RecruitingNot Applicable

Italian Digital Primary Cardiovascular Prevention Study

Italy27,520 participantsStarted 2022-06-10

Plain-language summary

The CV-PREVITAL study is a randomised clinical trial (RCT) controlled versus usual-care designed to compare the effectiveness of a mobile health (mHealth) intervention with that of usual care in reducing specific cardiovascular (CV) risk factors (in the short term) and the occurrence of vascular events (in the long term). Promoted by the Italian Network of Cardiology (ICN, a cardiovascular research network promoted by the Italian Ministry of Health), in collaboration with the Consorzio Sanità (Co.S., an Italian consortium of general practitioners), CV-PREVITAL aims to develop an innovative model of cardiovascular primary prevention and to validate it in a very large sample of subjects and in 'real life' conditions.

Who can participate

Age range45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subjects aged ≥ 45 years * Have given their consent to participate in the study * Subjects who have a smartphone Exclusion Criteria: * Current or previous cardiovascular disease (personal history of myocardial infarction, angina pectoris, arterial revascularization procedures, stroke, TIA, peripheral artery disease) * Psychiatric disorders * Participation in other clinical trials

What they're measuring

Cardiovascular risk as assessed by Modified Moli-Sani risk score in the Italian population

Timeframe: 12 months

Long-term CV clinical outcome at 7 years follow-up

Timeframe: 7 years

Trial details

NCT IDNCT05339841

SponsorCentro Cardiologico Monzino

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2029-06

View on ClinicalTrials.gov More Healthy Population trials